The guidelines for diagnosis and treatment of relapse /refractory acute myelogenous leukemia in China (2023).
- Collective Name:Leukemia & Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association
- Publication Type:Journal Article
- MeSH: Humans; Leukemia, Myeloid, Acute/therapy*; Acute Disease; Chronic Disease; Recurrence; China
- From: Chinese Journal of Hematology 2023;44(9):713-716
- CountryChina
- Language:Chinese